导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.72% | 493/1050 |
| 近一周 | -0.25% | 46/1104 |
| 近一月 | 2.72% | 21/1102 |
| 近一季 | 3.05% | 156/1092 |
| 近半年 | -0.42% | 429/1070 |
| 近一年 | 2.24% | 530/1018 |
| 近两年 | 37.19% | 618/926 |
| 近三年 | -4.96% | 714/834 |
| 成立以来 | 167.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.67% 435/1070 |
-8.39% 877/1101 |
- - |
- - |
| 2025 | 14.40% 766/1065 |
12.07% 98/1014 |
2.35% 480/1038 |
-3.22% 1024/1050 |
3.06% 239/1065 |
| 2024 | -9.38% 758/1011 |
-8.39% 713/960 |
-2.89% 498/983 |
6.71% 831/991 |
-4.54% 639/1011 |
| 2023 | -18.46% 635/952 |
5.37% 302/880 |
-9.32% 746/895 |
-7.94% 493/915 |
-7.31% 706/952 |
| 2022 | 1.04% 15/867 |
-9.87% 100/773 |
6.60% 429/806 |
-4.45% 56/845 |
10.07% 74/867 |
| 2021 | 28.92% 78/740 |
7.07% 29/580 |
4.13% 482/659 |
5.01% 126/704 |
10.11% 81/740 |
| 2020 | 16.16% 390/554 |
-13.69% 401/419 |
10.67% 393/466 |
14.13% 161/517 |
6.55% 410/554 |
| 2019 | 45.20% 182/410 |
26.19% 622/1149 |
-1.88% 511/1231 |
3.12% 249/390 |
13.72% 76/410 |
| 2018 | -0.69% 2/349 |
- - |
- - |
- - |
-4.26% 47/1080 |
| 2017 | -2.21% 182/285 |
- - |
- - |
- - |
- - |
| 2016 | -3.21% 36/205 |
- - |
- - |
- - |
- - |
| 2015 | 22.64% 53/151 |
- - |
- - |
- - |
- - |
| 2014 | 20.02% 13/24 |
- - |
- - |
- - |
- - |
| 2013 | 0.59% 18/21 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 诺安策略精选股票 VS. 东吴新产业精选股票A(580008) |